SFN
Each year, scientists from around the world congregate to discover new ideas, share their research, and experience the best the field has to offer. Attend so you can: present research, network with scientists, attend session and events, and browse the exhibit hall.
Join the nearly half a million neuroscientists from around the world who have propelled their careers by presenting an abstract at an SfN annual meeting — the premier global neuroscience event.
Each year, scientists from around the world congregate to discover new ideas, share their research, and experience the best the field has to offer. Attend so you can: present research, network with scientists, attend session and events, and browse the exhibit hall.
Join the nearly half a million neuroscientists from around the world who have propelled their careers by presenting an abstract at an SfN annual meeting — the premier global neuroscience event.
We’re proud to sponsor SFN 2025!
Neuroscience is evolving — and moving beyond animal models. At bit.bio, we’re enabling this shift with partnerships that provide access to precisely defined human cell models derived from the most relevant parental cell types.
Our ioCells deliver physiological relevance, reproducibility, and scalability for early drug discovery, phenotypic screening, and high-content imaging.
Visit our booth to experience the future of human neuroscience models and take the Neuron Building Challenge! See if you can top the leaderboard to win a Build-a-Neuron kit — prizes awarded daily. Compete with your colleagues and show who’s fastest!
We will be presenting the following posters:
- In vitro model to study demyelinating disease using human OPC- and oligodendrocyte-like cells generated by deterministic cell programming
- Identification of neuronal subtype-specific splice variants in iPSC-derived cell models of ALS and FTD
- A robust platform of human iPSC-derived motor neurons for ALS disease modelling and neurodegeneration focused drug discovery
- IPSC-derived Alzheimer’s disease models show increased secretion of pathogenic amyloid beta peptides in glutamatergic neurons and reduced inflammatory responses in microglia
- A versatile toolbox of human ipsc-derived microglia for disease modelling and multicellular in vitro models for neurodegeneration drug discovery
- Optimisation of mRNA delivery to overcome transfection challenges in hiPSC-derived neurons
Arrange a meeting